Search clinical trials for: Vandetanib
Total 103 results
-
National Cancer Institute (NCI)CompletedRenal Cancer | Von Hippel LindauUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerUnited States, France
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Medullary Thyroid CarcinomaUnited States
-
Samsung Medical CenterAstraZenecaCompleted
-
Genzyme, a Sanofi CompanyActive, not recruitingTo Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerThyroid CancerUnited States, Italy, Poland, Russian Federation, United Kingdom, Netherlands, Israel, Czechia, India
-
Genzyme, a Sanofi CompanyCompleted
-
M.D. Anderson Cancer CenterUnited States Department of Defense; AstraZenecaCompleted
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States
-
Genzyme, a Sanofi CompanyCompletedThyroid NeoplasmsSweden, France, Spain, Norway, Belgium, Denmark, Switzerland
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
Genzyme, a Sanofi CompanyCompletedEvaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer (VERIFY)Differentiated Thyroid CancerUnited States, Sweden, Brazil, Italy, Poland, Spain, China, Russian Federation, France, Japan, Denmark, Czechia
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerItaly, Spain, Romania, Netherlands, Canada, United States, Switzerland, Australia
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Renal Cell Cancer | Hereditary LeiomyomatosisUnited States
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyActive, not recruitingThyroid CancerUnited States, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, Sweden, Switz...
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, HepatocellularTaiwan
-
National Cancer Institute (NCI)Terminated
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation
-
Cancer Research UKAstraZenecaCompletedCancer | Non Small Cell Lung CancerUnited Kingdom
-
University of Colorado, DenverAstraZenecaCompleted
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNon-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)Completed
-
Genzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)TerminatedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States
-
Genzyme, a Sanofi CompanyTerminatedOvarian CancerGermany
-
National Cancer Institute (NCI)CompletedGlioblastoma Multiforme | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Anaplastic Mixed OligoastrocytomaUnited States
-
Ronald WeigelAstraZenecaTerminatedInvasive Breast CancerUnited States
-
SanofiTerminatedNon-small Cell Lung Cancer (NSCLC)Netherlands
-
PrECOG, LLC.AstraZenecaCompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
University of LiverpoolAstraZenecaUnknownPancreatic CancerUnited Kingdom
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedCarcinoma, Hepatocellular | Metastatic Colorectal CancerUnited Kingdom
-
SanofiCompletedPancreatic CancerSwitzerland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Terminated
-
Genzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)Terminated
-
Genzyme, a Sanofi CompanyCompletedCarcinoma | Lung Cancer | Non-Small Cell Lung
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, France, Italy, Korea, Republic of, Peru, Spain, United Kingdom, Philippines, China, Germany, Hong Kong, Argentina, Austria, Canada, Israel, Taiwan, Mexico, Thailand, Belgium, Australia, Singapore, Netherlands
-
SanofiCompleted
-
Hoffmann-La RocheWithdrawn
-
Genzyme, a Sanofi CompanyCompletedColorectal CancerUnited States, Korea, Republic of, Spain, United Kingdom, Norway, Argentina
-
University of Southern CaliforniaAstraZeneca; Celgene CorporationCompleted
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerItaly
-
Annick DesjardinsAstraZenecaCompletedGlioblastoma | GliosarcomaUnited States
-
University College, LondonAstraZeneca; Cancer Research UKWithdrawnParaganglioma | PhaeochromocytomaUnited Kingdom
-
SanofiCompleted
-
University of ChicagoNational Cancer Institute (NCI)CompletedPrecancerous Condition | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous CarcinomaUnited States